Enclot 250 mg (Capsule)
Medicine Details
| Category | Details |
|---|---|
| Generic | Tranexamic acid |
| Company | Opsonin pharma ltd |
| Also available as |
Title
Enclot
Categories
- Medicine
- Pharmacology
- Health & Wellness
Description
Enclot is a preparation of tranexamic acid used for prophylaxis and therapy of hemorrhagic syndromes in various medical fields such as medicine, surgery, urology, obstetrics, otorhinolaryngology, stomatology, and oncology.
Dimension
Standard tablet and injectable form
DosageForm
- Tablet
- Injection
DosageStrength
500mg, 1000mg
ColorOptions
- White
Function
Prophylaxis and antihemorrhagic therapy
Materials
Tranexamic acid (trans-4 aminomethyl-cyclohexanecarboxylic acid)
TechnicalSpecifications
Well absorbed by oral route, excreted mainly by renal route, extremely low acute toxicity
UsabilityFeatures
- Antifibrinolytic action
- Long-lasting effect
- Low thrombophilia tendency
DesignElements
Standard tablet shape
ModeOfAction
Inhibits plasminogen activation, 10 times more active than conventional hemostatics
Interactions
Incompatible with penicillins, antagonized by thrombolytic drugs
Contraindications
- Known individual hypersensitivity
- Thromboembolic disease
- Serious kidney failure
SideEffects
- Fatigue
- Conjunctival irritation
- Nasal blockage
- Itching
- Skin reddening
- Nausea
- Diarrhea
- Gastric pyrosis
- Postural hypotension
- Hypersensitivity reactions
PregnancyAndLactation
Avoid use during known and presumed pregnancy, passes into breast milk but unlikely to have antifibrinolytic effect in the infant
PrecautionsAndWarnings
- Use in hyperfibrinolysis cases
- Prophylactic treatment must begin 24 hours before the operation
- Prolonged therapy for at least 24 hours after manifestations have disappeared
- Use with caution in renal insufficiency
- Extra care in cardiopathic and hepatopathic subjects
TherapeuticClass
- Anti-fibrinolytic drugs
- Haemostatic drugs
StorageConditions
Store in a dry place at 15-30°C, away from light and keep out of children's reach